FINWIRES · TerminalLIVE
FINWIRES

Hong Kong Stocks Start Week Higher Amid Middle East Optimism; Cofoe Medical Prices IPO

By

Hong Kong equities gained on Monday amid renewed optimism over developments in the Middle East.

The Hang Seng Index rose by around 319.35 points, or roughly 1.2%, to end at 26,095.88. The Hang Seng China Enterprises Index increased by 92.56 points, or 1.1%, to close at 8,774.39.

Markets appeared to welcome signs of progress, however slow, in efforts by Iran and the U.S. to resolve the ongoing Middle East conflict, Reuters reported.

Iran is reviewing Washington's response to its 14-point proposal to end the conflict in the Middle East, while President Donald Trump said the U.S. would help countries with ships stranded in the Strait of Hormuz without disclosing details, Reuters reported.

In corporate news, Cofoe Medical Technology (HKG:1187, SHE:301087) priced its Hong Kong initial public offering of 27 million shares at HK$39.33 per share, the maximum price.

Related Articles

Asia

Atul Auto's Sales Rise 74% in April

Three-wheeler manufacturer Atul Auto's (NSE:ATULAUTO, BOM:531795) total sales jumped 74% to 3,001 units in April from 1,725 units sold a year ago, according to a Friday filing to the Indian stock exchanges.Of the total, domestic sales grew sharply year-on-year to 2,478 units in April from 1,427 units.

BOM:531795NSE:ATULAUTO
Asia

Leader Education's Fiscal H1 Profit Falls 17%

Leader Education (HKG:1449) booked 20.2 million yuan in attributable profit for the fiscal first half ended Feb. 28, down 17% from 24.2 million yuan a year earlier, according to a Hong Kong bourse filing Sunday.The higher education services company's shares fell nearly 2% in morning trade Monday.Earnings per share were 0.0303 yuan, compared with 0.0363 yuan in the prior-year period.Revenue rose 11% year on year to 191.3 million yuan, figures showed.

HKG:1449
Asia

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

CSL (ASX:CSL) led losses on the Australian bourse so far this year at AU$23.2 billion, while ResMed (ASX:RMD) and Cochlear (ASX:COH) followed with losses of AU$10.6 billion, the Australian Financial Review reported Monday, citing Global X ETFs.Negative performing companies on the S&P/ASX 200 index collectively wiped out over AU$217 billion, said Marc Jocum, senior product and investment strategist at Global X ETFs.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

ASX:COHASX:CSLASX:RMD